U.S. markets close in 4 hours 3 minutes

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9446+0.5727 (+153.99%)
As of 11:57AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.3719
Bid0.8862 x 3100
Ask0.8820 x 1300
Day's Range0.5900 - 0.9580
52 Week Range0.2750 - 18.6000
Avg. Volume3,686,539
Market Cap33.418M
Beta (5Y Monthly)-0.13
PE Ratio (TTM)N/A
EPS (TTM)-19.0060
Earnings DateAug 09, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.10
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for EVFM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Evofem Biosciences, Inc.
    Daily – Vickers Top Insider Picks for 09/10/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • MarketWatch

    Evofem's stock jumps 30% after Supreme Court decision on Roe v. Wade

    Shares of Evofem Biosciences Inc. soared 30.6% in trading on Friday, hours after the Supreme Court decision striking down Roe v. Wade was announced. Experts have speculated that the court's decision could lead to restrictions on birth control in the future although that was not included in Friday's decision. Evofem makes a non-hormonal gel that is used about an hour before sex to prevent pregnancy by controlling pH levels, which in turn lessens the mobility of sperm. It is prescribed by health c

  • PR Newswire

    Phexxi® Prevented 99% of Pregnancies Per Act of Intercourse in a Post Hoc Analysis of Phase 3 AMPOWER Clinical Trial Data

    Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial investigating the ability of Phexxi® (lactic acid, citric acid, and potassium bitartrate) to prevent pregnancy.


    Traders News Source Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier

    NEW YORK, NY / ACCESSWIRE / June 7, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a new C-Level interview with Evofem Biosciences. Mark Roberts, Senior Editor at Traders News Source had the opportunity to conduct the interview featuring Evofem Biosciences, Inc.